Dehydroevodiamine·HCl enhances cognitive function in memory-impaired rat models.
10.4196/kjpp.2017.21.1.55
- Author:
Ki Young SHIN
1
;
Ka Young KIM
;
Yoo Hun SUH
Author Information
1. Department of Microbiology, College of Natural Science, Dankook University, Cheonan 31116, Korea.
- Publication Type:Original Article
- Keywords:
Alzheimer's disease;
β-Amyloid;
Cognitive function;
Dehydroevodiamine;
Scopolamine
- MeSH:
Acetylcholine;
Alzheimer Disease;
Amnesia;
Animals;
Brain;
Calcium;
Cell Survival;
Cognition Disorders;
Cognition*;
Depression;
Dizocilpine Maleate;
Learning;
Memory;
Models, Animal*;
Neurodegenerative Diseases;
Neurons;
Rats*;
Reactive Oxygen Species;
Scopolamine Hydrobromide;
Spatial Memory;
Stroke;
Water
- From:The Korean Journal of Physiology and Pharmacology
2017;21(1):55-64
- CountryRepublic of Korea
- Language:English
-
Abstract:
Progressive memory impairment such as that associated with depression, stroke, and Alzheimer's disease (AD) can interfere with daily life. In particular, AD, which is a progressive neurodegenerative disorder, prominently features a memory and learning impairment that is related to changes in acetylcholine and abnormal β-amyloid (Aβ) deposition in the brain. In the present study, we investigated the effects of dehydroevodiamine·HCl (DHED) on cognitive improvement and the related mechanism in memory-impaired rat models, namely, a scopolamine-induced amnesia model and a Aβ₁₋₄₂-infused model. The cognitive effects of DHED were measured using a water maze test and a passive avoidance test in the memory-impaired rat models. The results demonstrate that DHED (10 mg/kg, p.o.) and Donepezil (1 mg/kg, p.o.) ameliorated the spatial memory impairment in the scopolamine-induced amnestic rats. Moreover, DHED significantly improved learning and memory in the Aβ₁₋₄₂-infused rat model. Furthermore, the mechanism of these behavioral effects of DHED was investigated using a cell viability assay, reactive oxygen species (ROS) measurement, and intracellular calcium measurement in primary cortical neurons. DHED reduced neurotoxicity and the production of Aβ-induced ROS in primary cortical neurons. In addition, similar to the effect of MK801, DHED decreased intracellular calcium levels in primary cortical neurons. Our results suggest that DHED has strong protective effects against cognitive impairments through its antioxidant activity and inhibition of neurotoxicity and intracellular calcium. Thus, DHED may be an important therapeutic agent for memory-impaired symptoms.
